Skip to content

Author

Edmund V. Capparelli

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Safety, antiviral activity, and pharmacokinetics of long-acting cabotegravir plus long-acting rilpivirine in virologically suppressed adolescents living with HIV-1 (IMPAACT 2017/MOCHA): week 96 and end-of-study results from a multinational, phase 1/2, single-arm trial.

BACKGROUND Week 24 and week 48 study data from the International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT 2017)/More Options for Children and Adolescents (MOCHA) trial supported the use of long-acting cabotegravir plus long-acting rilpivirine, given every 4 weeks or 8 weeks, per the adult dos...

Carolyn Bolton Moore, K. Baltrusaitis, Edmund V. Capparelli et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.